ArticleScientific reports2024

Risk of stress cardiomyopathy associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors: a real-world pharmacovigilance analysis.

Boyu Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.